Skip to main content
. 2019 Mar 30;7(2):26. doi: 10.3390/biomedicines7020026

Table 1.

Immunoablation regimens.

Intensity Regimen
High High dose of busulfan combined with cyclophosphamide and ATG
Intermediate BEAM (BCNU, etoposide, cytosine arabinoside, melphalan) +/− ATG
Low (nonmyeloablative) Cyclophosphamide and ATG